Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29190626)

  • 1. SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis.
    Hu H; Cai W; Zheng S; Ge W
    Cell Physiol Biochem; 2017; 44(4):1485-1496. PubMed ID: 29190626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers.
    Hu H; Zhang H; Ge W; Liu X; Loera S; Chu P; Chen H; Peng J; Zhou L; Yu S; Yuan Y; Zhang S; Lai L; Yen Y; Zheng S
    Clin Cancer Res; 2012 Oct; 18(19):5438-48. PubMed ID: 22891198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer.
    Zhang HP; Wu J; Liu ZF; Gao JW; Li SY
    Biomed Res Int; 2022; 2022():1398268. PubMed ID: 35111844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.
    Yu Y; Chen Y; Ma J; Yu X; Yu G; Li Z
    Tumour Biol; 2016 Mar; 37(3):4159-67. PubMed ID: 26490986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
    Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
    Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
    Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
    J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis.
    Cheng F; Zeng C; Zeng L; Chen Y
    Medicine (Baltimore); 2019 Oct; 98(40):e17310. PubMed ID: 31577724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.
    Zhang M; Dong Y; Liu H; Wang Y; Zhao S; Xuan Q; Wang Y; Zhang Q
    Sci Rep; 2016 Nov; 6():37933. PubMed ID: 27892511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPARCL1 expression increases with preoperative radiation therapy and predicts better survival in rectal cancer patients.
    Kotti A; Holmqvist A; Albertsson M; Sun XF
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1196-202. PubMed ID: 24661672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
    Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
    PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis.
    Yin S; Huang J; Li Z; Zhang J; Luo J; Lu C; Xu H; Xu H
    PLoS One; 2017; 12(1):e0170042. PubMed ID: 28081243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors.
    Shen C; Yin Y; Chen H; Wang R; Yin X; Cai Z; Zhang B; Chen Z; Zhou Z
    BMC Gastroenterol; 2018 Jul; 18(1):105. PubMed ID: 29973149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
    Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
    Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis.
    Zhu J; Xue Z; Zhang S; Guo X; Zhai L; Shang S; Zhang Y; Lu H
    Int J Surg; 2018 Sep; 57():76-83. PubMed ID: 30103072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.
    Yu SJ; Yu JK; Ge WT; Hu HG; Yuan Y; Zheng S
    World J Gastroenterol; 2011 Apr; 17(15):2028-36. PubMed ID: 21528083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic and Clinicopathological Roles of Sirtuin-3 in Various Cancers.
    Yu FY; Xu Q; Wu DD; Lau AT; Xu YM
    PLoS One; 2016; 11(8):e0159801. PubMed ID: 27483432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of reduced SPARCL1 expression in human breast cancer.
    Cao F; Wang K; Zhu R; Hu YW; Fang WZ; Ding HZ
    Asian Pac J Cancer Prev; 2013; 14(1):195-200. PubMed ID: 23534723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
    Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
    BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.
    Lu L; Huang F; Zhao Z; Li C; Liu T; Li W; Fu W
    Medicine (Baltimore); 2016 Dec; 95(50):e5603. PubMed ID: 27977599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.